The conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation

Shahrad Hakimian,1 Yevgeniy Popov,1 Abbas H Rupawala,2 Karen Salomon-Escoto,3 Steven Hatch,4 Randall Pellish1,2 1Department of Medicine, 2Division of Gastroenterology, 3Division of Rheumatology, 4Division of Infectious Disease, UMass Memorial Medical Center, Worcester, MA, USA Background: Tumor necr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hakimian S, Popov Y, Rupawala AH, Salomon-Escoto K, Hatch S, Pellish R
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/d9826e472f5747949dfcb09d3002e73c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d9826e472f5747949dfcb09d3002e73c
record_format dspace
spelling oai:doaj.org-article:d9826e472f5747949dfcb09d3002e73c2021-12-02T07:15:07ZThe conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation1177-5491https://doaj.org/article/d9826e472f5747949dfcb09d3002e73c2018-02-01T00:00:00Zhttps://www.dovepress.com/the-conundrum-of-indeterminate-quantiferon-tb-gold-results-before--ant-peer-reviewed-article-BTThttps://doaj.org/toc/1177-5491Shahrad Hakimian,1 Yevgeniy Popov,1 Abbas H Rupawala,2 Karen Salomon-Escoto,3 Steven Hatch,4 Randall Pellish1,2 1Department of Medicine, 2Division of Gastroenterology, 3Division of Rheumatology, 4Division of Infectious Disease, UMass Memorial Medical Center, Worcester, MA, USA Background: Tumor necrosis factor alpha (TNFα) is a key cytokine in both the pathogenesis of inflammatory bowel disease (IBD) and rheumatoid arthritis (RA) and the host defense against tuberculosis (TB). Consequently, anti-TNFα medications result in an increased risk of latent TB infection (LTBI) reactivation. Here, we sought to evaluate the factors affecting the results of QuantiFERON-TB Gold In-Tube (QFT-GIT) assay as a screening tool for LTBI. Methods: We conducted an observational, retrospective study in patients with IBD and RA who underwent LTBI screening using QFT-GIT at UMass Memorial Medical Center between 2008 and 2016 prior to initiation of anti-TNF medications. Results: We included 107 and 89 patients with IBD and RA, respectively. We found that a higher proportion of IBD patients had indeterminate QFT-GIT result compared to RA patients. Furthermore, we found that the majority of patients with indeterminate results were tested during an acute flare of IBD (88%) and while taking corticosteroids. Of all patients receiving ≥20 mg equivalent prednisone dose (n=32), 63% resulted in indeterminate QFT-GIT, compared to only 6% indeterminate testing in patients receiving <20 mg of equivalent prednisone dose (n=164, P<0.001). There was no correlation between indeterminate results and age, gender, disease duration, or distribution, or smoking status within each population. Conclusion: We observed that high-dose corticosteroids may affect QFT-GIT outcomes leading to a high proportion of indeterminate results. We propose that IBD patients should be tested prior to initiation of corticosteroids to avoid equivocal results and prevent potential delays in initiation of anti-TNF medications. Keywords: indeterminate QuantiFERON-TB Gold, latent TB infection, inflammatory bowel disease, rheumatoid arthritis, corticosteroids, IBD flareHakimian SPopov YRupawala AHSalomon-Escoto KHatch SPellish RDove Medical PressarticleIndeterminate Quantiferon GoldLatent TB infectionInflammatory Bowel DiseaseRheumatoid ArthritisMedicine (General)R5-920ENBiologics: Targets & Therapy, Vol Volume 12, Pp 61-67 (2018)
institution DOAJ
collection DOAJ
language EN
topic Indeterminate Quantiferon Gold
Latent TB infection
Inflammatory Bowel Disease
Rheumatoid Arthritis
Medicine (General)
R5-920
spellingShingle Indeterminate Quantiferon Gold
Latent TB infection
Inflammatory Bowel Disease
Rheumatoid Arthritis
Medicine (General)
R5-920
Hakimian S
Popov Y
Rupawala AH
Salomon-Escoto K
Hatch S
Pellish R
The conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation
description Shahrad Hakimian,1 Yevgeniy Popov,1 Abbas H Rupawala,2 Karen Salomon-Escoto,3 Steven Hatch,4 Randall Pellish1,2 1Department of Medicine, 2Division of Gastroenterology, 3Division of Rheumatology, 4Division of Infectious Disease, UMass Memorial Medical Center, Worcester, MA, USA Background: Tumor necrosis factor alpha (TNFα) is a key cytokine in both the pathogenesis of inflammatory bowel disease (IBD) and rheumatoid arthritis (RA) and the host defense against tuberculosis (TB). Consequently, anti-TNFα medications result in an increased risk of latent TB infection (LTBI) reactivation. Here, we sought to evaluate the factors affecting the results of QuantiFERON-TB Gold In-Tube (QFT-GIT) assay as a screening tool for LTBI. Methods: We conducted an observational, retrospective study in patients with IBD and RA who underwent LTBI screening using QFT-GIT at UMass Memorial Medical Center between 2008 and 2016 prior to initiation of anti-TNF medications. Results: We included 107 and 89 patients with IBD and RA, respectively. We found that a higher proportion of IBD patients had indeterminate QFT-GIT result compared to RA patients. Furthermore, we found that the majority of patients with indeterminate results were tested during an acute flare of IBD (88%) and while taking corticosteroids. Of all patients receiving ≥20 mg equivalent prednisone dose (n=32), 63% resulted in indeterminate QFT-GIT, compared to only 6% indeterminate testing in patients receiving <20 mg of equivalent prednisone dose (n=164, P<0.001). There was no correlation between indeterminate results and age, gender, disease duration, or distribution, or smoking status within each population. Conclusion: We observed that high-dose corticosteroids may affect QFT-GIT outcomes leading to a high proportion of indeterminate results. We propose that IBD patients should be tested prior to initiation of corticosteroids to avoid equivocal results and prevent potential delays in initiation of anti-TNF medications. Keywords: indeterminate QuantiFERON-TB Gold, latent TB infection, inflammatory bowel disease, rheumatoid arthritis, corticosteroids, IBD flare
format article
author Hakimian S
Popov Y
Rupawala AH
Salomon-Escoto K
Hatch S
Pellish R
author_facet Hakimian S
Popov Y
Rupawala AH
Salomon-Escoto K
Hatch S
Pellish R
author_sort Hakimian S
title The conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation
title_short The conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation
title_full The conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation
title_fullStr The conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation
title_full_unstemmed The conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation
title_sort conundrum of indeterminate quantiferon-tb gold results before anti-tumor necrosis factor initiation
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/d9826e472f5747949dfcb09d3002e73c
work_keys_str_mv AT hakimians theconundrumofindeterminatequantiferontbgoldresultsbeforeantitumornecrosisfactorinitiation
AT popovy theconundrumofindeterminatequantiferontbgoldresultsbeforeantitumornecrosisfactorinitiation
AT rupawalaah theconundrumofindeterminatequantiferontbgoldresultsbeforeantitumornecrosisfactorinitiation
AT salomonescotok theconundrumofindeterminatequantiferontbgoldresultsbeforeantitumornecrosisfactorinitiation
AT hatchs theconundrumofindeterminatequantiferontbgoldresultsbeforeantitumornecrosisfactorinitiation
AT pellishr theconundrumofindeterminatequantiferontbgoldresultsbeforeantitumornecrosisfactorinitiation
AT hakimians conundrumofindeterminatequantiferontbgoldresultsbeforeantitumornecrosisfactorinitiation
AT popovy conundrumofindeterminatequantiferontbgoldresultsbeforeantitumornecrosisfactorinitiation
AT rupawalaah conundrumofindeterminatequantiferontbgoldresultsbeforeantitumornecrosisfactorinitiation
AT salomonescotok conundrumofindeterminatequantiferontbgoldresultsbeforeantitumornecrosisfactorinitiation
AT hatchs conundrumofindeterminatequantiferontbgoldresultsbeforeantitumornecrosisfactorinitiation
AT pellishr conundrumofindeterminatequantiferontbgoldresultsbeforeantitumornecrosisfactorinitiation
_version_ 1718399547412054016